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The aspartate pathway of amino acid biosynthesis is essential for all microbial life but is absent in mammals. Characterizing
the enzyme-catalyzed reactions in this pathway can identify new protein targets for the development of antibiotics with unique
modes of action. The enzyme aspartate β-semialdehyde dehydrogenase (ASADH) catalyzes an early branch point reaction in
the aspartate pathway. Kinetic, mutagenic, and structural studies of ASADH from various microbial species have been used
to elucidate mechanistic details and to identify essential amino acids involved in substrate binding, catalysis, and enzyme
regulation. Important structural and functional diﬀerences have been found between ASADHs isolated from these bacterial
and fungal organisms, opening the possibility for developing species-speciﬁc antimicrobial agents that target this family of
enzymes.
1.Introduction
Enzyme-catalyzed reactions organized into sequential path-
ways are responsible for producing the molecules needed to
sustain life. While many essential metabolic pathways are
present in all known life forms, there are also signiﬁcant
diﬀerences between microbial and mammalian metabolism.
Most microbial species can synthesize all of their important
metabolic building block molecules, while mammals must
acquire many of these from dietary sources. These metabolic
diﬀerences provide a substantial number of potential protein
targets to be examined for the development of selective
antimicrobial agents. There is a growing need to identify
eﬀective new antibiotics that function against new targets to
combat the expanding threat from pathogenic species that
are becoming increasingly resistant to existing antibiotics
[1, 2]. There are, however, fundamental problems that must
be resolved for eﬀective biocides to be developed against
metabolic enzyme targets. Infectious microorganisms often
use their host as a source of essential metabolites, thus
bypassing inhibitors designed to block key steps in micro-
bial metabolism. In many instances microorganisms have
developed alternative routes for the production of important
metabolites that can readily bypass inhibited enzyme reac-
tions [3]. Essential enzymatic pathways can also be altered
in response to an antibiotic threat. Although these microbial
pathways may not exist in mammals, related enzymes with
similar active site geometries or substrate binding motifs can
potentially interact with even the most carefully designed
inhibitors. The structure and mechanism of a bacterial
metabolic enzyme must be thoroughly characterized before
a potential drug target can be fully evaluated. Aspartate β-
semialdehydedehydrogenase(ASADH)isakeyenzymeinan
essential amino acid biosynthetic pathway that is not present2 Journal of Amino Acids
in mammals. This enzyme has been thoroughly investigated
and is now being examined as a target for the development
of new antimicrobial agents.
2.TheAspartateBiosynthetic
PathwayinMicrobes
The aspartate biosynthetic pathway is present only in plants
and microbes. The commitment step to this pathway is
the phosphorylation of aspartic acid catalyzed by a family
of aspartokinases (AK). The next enzyme in the pathway,
ASADH, catalyzes the production of aspartate semialdehyde
(ASA) that is located at a critical junction in this pathway.
From this point one pathway branch leads to the production
of lysine through the metabolite diaminopimelate, while
the alternative route leads to the synthesis of methionine,
threonine, and isoleucine with homoserine serving as their
common intermediate (Figure 1). Thus, one quarter of the
amino acids required for protein synthesis in all organisms
are linked through and synthesized by this pathway [4]. The
aspartate pathway is exquisitely regulated to control the total
amino acid output as well as the relative levels of each amino
acid. This regulatory scheme must also maintain the levels of
several essential metabolic intermediates during periods of
low protein synthesis. This is accomplished by coordinated
regulation by the end product amino acids, both through
feedback inhibition and by selective gene repression [5]. This
regulatory scheme allows each end product to modulate the
ﬂux through the initial pathway steps, with branch point
allostericenzymesprovidingfurthercontrolovertheproduct
levels.
In addition to the essential amino acids produced in
the aspartate pathway, several important metabolites are
synthesized that play crucial roles in important develop-
mental processes, such as cell wall biosynthesis, protective
dormancy, and virulence factor production. For example,
dihydrodipicolinate is a precursor of dipicolinate, the major
component of bacterial spores [6], and diaminopimelate
(DAP) is required for cross-linking of the peptidoglycan
polymers [7] in bacterial cell wall synthesis (Figure 1).
Another product of this pathway, S-adenosylmethionine, is
an essential methyl group donor that also serves as a precur-
sorforquorumsensingsignalingmoleculeswithcriticalroles
in triggering virulence factors in infectious microorganisms
[8, 9]. Homoserine lactone signals, for example, are essential
for both virulence and bioﬁlm development in the human
pathogen Acinetobacter baumannii [10].
Because this pathway produces many essential com-
pounds that are involved in a range of critical functions, dis-
ruptions to the aspartate pathway are fatal to those microor-
ganisms. In particular, selective perturbations of the asd gene
that encodes for ASADH are lethal to numerous infectious
microorganisms. For example, asd mutants of Salmonella
typhimurium develop an absolute growth requirement for
diaminopimelate (DAP), a critical cell wall cross-linking
component (Figure 1) in Gram-negative bacteria [11]. This
mutated organism undergoes cell lysis when DAP is not
supplied, and, since this metabolite is not produced in
mammals it cannot be supplied by the host organism.
A similar loss of viability is observed in asd-deﬁcient E.
coli strains. During amino acid starvation microorganisms
often use speciﬁc transport systems to import exogenous
amino acids available from the host environment [12].
However, de novo biosynthesis of lysine is essential for the
survival of Mycobacterium tuberculosis during infection in
mice, despite the presence of lysine in the host [13]. Even
if an organism could mutate to improve lysine transport
capacity in response to aspartate pathway inhibition, reversal
of the decarboxylation that produces lysine from DAP is
neither kinetically nor thermodynamically feasible. Both of
these end products and several additional intermediates of
this pathway are thus critical for microbial cell viability,
both in culture and during host infection. Blockage of
the aspartate pathway is fatal to microorganisms. Therefore
the identiﬁcation of eﬀective inhibitors of key aspartate
pathway enzymes should provide lead compounds for the
development of new biocides. To achieve this aim we have
focused on the functional and structural characterization of
the microbial ASADH family of enzymes.
3.Seq ue nc eandS tructuralC o mpariso ns
among the Aspartate-β-Semialdehyde
Dehydrogenases
Aspartate-β-semialdehyde dehydrogenase (ASADH) cat-
alyzes the second reaction in the aspartate pathway, the
reductive dephosphorylation of β-aspartyl phosphate to
aspartate-β-semialdehyde (ASA) (Scheme 1), at a critical
branch point in this pathway.
The ASADHs from a variety of organisms encompass
a considerable diversity of sequence homologies, ranging
from less than 10% to as high as 95% sequence identity
when compared to the Escherichia coli enzyme (ecASADH).
The ASADH enzymes in microorganisms can be divided
into three branches consisting of the enzymes from Gram-
negativebacteria,Gram-positivebacteria,andarchaea/fungi.
These branches were initially identiﬁed and partitioned
through sequence alignments and now, with representative
high resolution structures available from each branch,
have been compared by structural alignments. The earliest
structures of ASADHs are from enzymes that were isolated
and puriﬁed from Gram-negative bacteria. These enzyme
forms share signiﬁcant sequence and structural homology
and include structures of the ASADHs from E. coli [14,
15], Vibrio cholerae [16], and Haemophilus inﬂuenzae [17].
The overall structure of these ASADHs is a homodimer
with an extensive contact surface between the subunits.
Each monomer is composed of a carboxy-terminal domain
primarily involved in hydrophobic intersubunit contacts,
and a more hydrophilic amino-terminal domain that forms
the active site and NADP binding site (Figure 2).
The ASADH from Streptococcus pneumoniae (spASADH)
is the ﬁrst member of the Gram-positive bacterial branch
that was structurally characterized [18]. spASADH is a
good representative of the other Gram-positive bacterial
ASADHs with greater than 40% sequence identity to these
enzymes, while having less than 25% identity with any ofJournal of Amino Acids 3
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Figure 1: The aspartate biosynthetic pathway in microorganisms. The end product amino acids produced by this pathway are shown in
green. Pathway-speciﬁc metabolites (shown in red) play crucial roles in microbial life cycle functions (shown in blue).
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Scheme 1: The conversion of aspartate β-semialdehyde to β-aspartyl phosphate catalyzed by aspartate β-semialdehyde dehydrogenase in the
reverse (nonphysiological) reaction.
the Gram-negative enzymes. Unexpectedly, this spASADH
haslowersequencehomologytotheGram-negativeenzymes
than to those of the archaeal/fungal branch, with sequence
identities from this comparison ranging from 18 to 30%.
The structure of the ASADH from the archaeal hyperther-
mophile Methanococcus jannaschii (mjASADH) has a similar
overall fold and domain arrangement as the Gram-negative
enzyme forms [19] despite being less than 10% sequence
identity. But the complete set of functionally important
active site amino acids has been conserved in mjASADH,
suggesting an identical mechanism in the enzyme from
this ancient organism despite its lower catalytic eﬃciency.
The ﬁrst structure of an ASADH from a fungal species,
Candida albicans (caASADH), was recently determined, and
it also possesses a similar overall fold, domain organization,
and active site structure as the other members of this
enzyme family [20]. This fungal enzyme has less than 30%
sequence identity to any of the bacterial ASADHs and only
40% identity to its closest homologue. Alignment of the
structures that have been determined from each branch
of the ASADH family shows that both spASADH and
caASADH are most similar to the archaeal ASADH from M.
jannaschii and more distantly related to the Gram-negative
enzymes.
Despite the overall sequence and structural similarities,
there are a number of insertions and deletions which
serve to diﬀerentiate the three ASADH branches. Structural
variations between these branches include a sequence of
residuesontheenzymesurfacethatcontributetothebinding
pocket for the coenzyme NADP. The E. coli ASADH is
representative of the Gram-negative enzymes, with a highly
ﬂexible coenzyme binding loop in the absence of NADP that
becomes ordered in response to NADP binding [15]. The
archaeal mjASADH has three conserved insertions totalling
30residueswhenalignedagainsttheGram-negativebacterial
ecASADH [19], with each insertion located on the surface
of the structure. A 13-residue insertion in mjASADH leads
to an alternative orientation of the coenzyme binding loop,
diﬀering from that in the Gram-negative enzymes by about
90◦, causing it to drape over and occlude the coenzyme
binding pocket [19]. In addition, the helical subdomain
that comprises a signiﬁcant fraction of the dimer interface
(Figure 2) is absent in the archaeal mjASADH. The Gram-
positive spASADH has the same number of residues in
this region as the Gram-negative bacterial enzymes, but
two short β-strands replace the helix-turn-helix structure
observed in the helical subdomain of ecASADH (Figure 2).
ThefungalenzymefromC.albicansisalsomissingthehelical4 Journal of Amino Acids
subdomain [20] and contains most of the insertions and
deletions observed in the archaeal enzyme. These structural
changes suggest diﬀerences in how each branch of this
enzyme family can carry out its catalytic role, even though
each possesses an identical repertoire of highly conserved
active site functional groups.
4.RoleofActiveSiteFunctionalGroups
Inspiteoftheoverallsequencediversitybetweenthediﬀerent
branches of the ASADH family the identity of the core
active site functional groups has been preserved throughout
evolution (Figure 3). A set of active site mutants of ASADH
from H. inﬂuenzae (hiASADH) was examined kinetically
and structurally with the goal of more precisely establishing
the role for each functional group in substrate recognition
and binding. A cysteine had been previously identiﬁed from
biochemical studies as the likely active site nucleophile [21].
Replacement of a single sulfur atom with an oxygen in
the C136S mutant virtually eliminates catalysis (Table 1),
supporting the essential role of this residue as the catalytic
nucleophile. Some decrease in catalytic activity would be
expected because the hydroxyl group of serine is a weaker
nucleophile than a cysteine sulfhydryl group. Only minor
changes are observed in the active site structure of this
mutant despite the nearly complete loss of catalytic activity.
But a change in orientation of the introduced hydroxyl
group is likely responsible for the very low activity of this
mutant. The side chain hydroxyl group of the introduced
serine rotates by about 90 degrees, with this new orientation
stabilized by a hydrogen-bond to an adjacent backbone
carbonyl group [22]. This reorientation not only moves this
functional group out of the position needed to act as a
nucleophile, but also competes with the involvement of this
backbone carbonyl in intermediate stabilization and alters
the position of the bound phosphate group.
Mammalian glyceraldehyde-3-phosphate dehydrogenase
(GAPDH)catalyzesasimilarreaction,anoxidativephospho-
rylation, to the reverse reaction catalyzed by ASADH and
appears to do so by the same mechanism [23]. Before the
ﬁrst structure of ASADH was available, sequence alignments
to the mechanistically related enzyme (GAPDH) family were
used to identify and then test the roles of possible active site
functional groups. Both enzymes were proposed to contain a
cysteine-histidine catalytic dyad; however the corresponding
position of the catalytic histidine in GAPDH is occupied by
a conserved glutamine in ASADH [24]. Replacement of this
functional amino acid causes a loss in catalytic activity that is
notfullyrecoveredevenwhenahistidineisintroducedatthis
position in ASADH. This mystery was solved when the ﬁrst
ASADHstructurerevealedthattheessentialhistidineresidue
actually comes from a completely diﬀerent position in the
primary sequence, with a loop containing H277 folded into
the enzyme active site [14]. The H277N mutant of hiASADH
has signiﬁcantly impaired activity (Table 1), highlighting
the key role for this residue. However a ternary complex
structure with NADP and the active site-directed inactivator,
S-methyl-L-cysteine sulfoxide (SMCS), showed continuous
density extending from the Cys136 nucleophile [22]. This
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Figure 2: Ribbon drawing and surface rendering of the ASADH
from Escherichia coli showing the overall structure. Each of the
ASADH structures shares a conserved domain organization and
exists as a functional homodimer. The largest structural diﬀerences
between the diﬀerent branches of this enzyme family manifest
themselves in the coenzyme binding loop and in the helical sub-
domain bridging the dimerization interface. The bound coenzyme
NADP and the active site amino acids are shown in one subunit as
blue sticks.
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Figure 3: The active site structure of Vibrio cholerae ASADH with
bound NADP and the covalent inactivator SMCS (shown in green).
Cys134 is the active site nucleophile, and His274 is the acid-base
catalyst. Glu240 and Arg267 are substrate binding groups, with
Arg101 and Lys243 comprising part of the phosphate binding
site that is occupied in this structure by a water molecule (W2).
H. inﬂuenzae numbering is in parentheses (ﬁgure adapted from
reference [16]).
structure is consistent with the covalent attachment of SMCS
to the active site nucleophile. The position of this bound
inactivator is shifted in the H277N mutant relative to its
position when bound in the wild-type enzyme [15]. This
reorientation moves this compound further from the bound
phosphate that must attack the carbonyl carbon of the acyl-
enzyme intermediate to generate β-aspartyl phosphate in the
reverse reaction (Scheme 1).Journal of Amino Acids 5
Table 1: Kinetic and structural consequences of ASA dehydrogenase active site mutants.
Active site groupa Proposed function Mutant Catalytic
activityb Structural eﬀect of the mutation PDB code
Cys136 (Cys134) Active site
nucleophile C136S <0.01%
Rotation of S136 shifts the amino
g r o u po fA S Aa n dm o v e st h eb o u n d
phosphate by 1 ˚ A
1PQP
His277 (His274) Acid-base catalyst H277N 1.0%
Breakdown of the initial tetrahedral
intermediate is slowed by a shift in
the phosphate position
1PQU
Arg270 (Arg267) Binds the substrate
carboxyl group
R270K
R267L
0.1%
9.5%
The introduced lysine moves about
2 ˚ A away from the original arginine
position
1PS8
Glu243 (Glu240) Binds the substrate
amino group E243D 1.2%
The bound intermediate shifts
position by about 0.5 ˚ A towards the
shorter side chain of D243
1Q2X
Lys246 Helps orient
bound phosphate K246R 3.3%
The introduced arginine rotates by
about 90◦ to form new interactions
with S99 and K242
1PU2
Arg103 Binds phosphate R103K
R103L
0.4%
0.07%
Displaces the active site loop (N135
to S139) which shifts C136 away
from H277
1PR3
1OZA
aH. inﬂuenzae sequence numbering, with the numbers in parenthesis referring to the V. cholerae sequence
bkcat determined by varying ASA at ﬁxed NADP levels and expressed as a percent of wild type enzyme activity
So in summary for these catalytic mutants, the C136S
mutant still allows substrate binding but formation of the
covalently bound intermediate is slowed by a less eﬃcient
andmisorientednucleophile.Incontrast,theH277Nmutant
appears to form the initial tetrahedral intermediate eﬃ-
ciently, but its subsequent breakdown is hindered by a shift
away from the bound phosphate nucleophile. In each case,
small perturbations in the positioning of essential catalytic
groups or reactive intermediates are shown to have dramatic
eﬀects on enzyme catalysis.
Additional mutant structures of hiASADH have been
determined, with each substitution replacing a putative sub-
strate binding group in order to assess their function. Each
of these mutants displayed signiﬁcantly impaired catalytic
activity, ranging from ∼10% to less than 0.1% that of the
wild-type enzyme [25]. However, the structural basis for the
diminished activities is diﬀerent for each mutation (Table 1).
A conserved arginine (Arg270) in the ASADH family aligns
withaconservedArg231intheGAPDHfamily,aresiduethat
had previously been assigned a role in binding the substrate
phosphate group [26]. Based on kinetic studies this arginine
residuewasproposedtohaveacomparableroleinhiASADH,
namely, binding the carboxyl group of the substrate ASA
[24]. The structures of substrate complexes of the wild-type
enzyme [17] and of the inactivator SMCS covalently bound
to Vibrio cholerae ASADH (vcASADH) [16] support this
assignment by clearly establishing the presence of a bidentate
interaction between Arg270 and the carboxylic group of the
substrate ASA.
Arginine270 was replaced by lysine in hiASADH to assess
its relative importance in substrate binding by disrupting the
bidentate interaction that is formed with ASA. Maintaining
this interaction between the introduced lysyl amino group
and the ASA carboxyl group will require a shift in the
orientation of both the lysyl side chain and the resulting
tetrahedral intermediate relative to their positions in the
wild-type enzyme. The dramatic loss of activity in R270K
can be explained by a shift of the intermediate away from
the position that is necessary to form and maintain a
productive interaction between its carboxyl group and the
altered substrate binding residue during the catalytic cycle. A
neutral side chain introduced at this position in ecASADH
(R267L) cannot form any binding interaction with the
substrate carboxyl group, leading to a 30-fold increase in
the Km for ASA [24] while also permitting greater ﬂexibility
for positioning of the covalent intermediate. This ﬂexibility
increases the likelihood that the intermediate can adopt a
catalytically viable conformation relative to that imposed
in the hiASADH R270K mutant, and this conformational
ﬂexibility is manifest in the 100-fold greater activity seen in
the R267L ecASADH enzyme form (Table 1).
Glutamate243providesasidechaincarboxylgroupinthe
activesiteofASADHwhoseroleinthecatalyticcyclehadnot
been deﬁnitively established. This group is highly conserved
among ASADHs from diﬀerent organisms, and structural
studies have shown that it is in position to potentially
interactwiththeaminogroupofthetetrahedralintermediate
in the hiASADH complex [17]. An E243D mutant was
produced to assess the possible role of this residue in
substrateandintermediatebinding.KineticstudiesofE243D
failed to show the expected detrimental eﬀect on substrate
interactions, with the Km for ASA unchanged from that of
the wild-type enzyme. Instead the catalytic eﬃciency of this
mutant is signiﬁcantly compromised, reducing the kcat value
to about 1% of that of wild-type hiASADH (Table 1). In this
casethepositionoftheboundintermediate(andpresumably6 Journal of Amino Acids
that of the bound substrate) shifts towards the shorter side
chain of the introduced aspartate at this position. This shift
allows this mutant to maintain substrate binding aﬃnity,
but compromises the positioning between the intermediate
and the bound cofactor thereby leading to impaired catalytic
eﬃciency.
Each of these mutations was prepared with the aim
of removing and testing critical substrate binding groups.
However the structural rearrangements that occur as a
consequence of these replacements manifest themselves not
in a loss in substrate binding aﬃnity, but in a loss of catalytic
activity. Structural characterization of these mutants shows
that only subtle changes in key active site residues, such as
rotation of a side chain to form a new hydrogen-bond or
a shift in position relative to a catalytic intermediate, are
suﬃcient to adversely aﬀect catalysis.
The phosphate-binding site of ASADH is capable of
accommodating diﬀerent tetrahedral oxyanion analogues
[27], leading to diﬀerent functional consequences. Both
oxyanion substrates and oxyanion inhibitors bind in the
same position by using the same set of ligands (Figure 4),
raising the question of what distinguishes a substrate
from an inhibitor? In the apoenzyme the side chain
hydroxyl of Thr137 forms a hydrogen-bond with Asn135,
and this pairing prevents any interactions with the active
site Glu243. Upon binding of either oxyanion substrate,
phosphate or arsenate, Thr137 switches hydrogen-bonding
partners through a 60◦ rotation that disrupts its interaction
with Asn135. This new conformation moves the threonine
hydroxyl group into position to interact with and orient
Glu243, an important substrate binding group. Glu243
remains in this substrate binding position in the arsenate
structure, and this hydrogen-bond with the Thr137 hydroxyl
group persists even in the absence of bound ASA. So,
the presence of an oxyanion substrate in the active site
helps to position Glu243 to interact with the substrate.
However, in the presence of the inhibitor periodate this
threonine does not change position and switch partners. In
this inhibitor-bound structure Thr137 remains hydrogen-
bonded to Asn135, which is now oriented away from Glu243
and cannot stabilize the position of this side chain. This
single change in hydrogen-bonding partners is apparently
suﬃcient to interfere with the binding of ASA. Thus, subtle
shifts in the position of side chains, even those not directly
involved in substrate binding or catalysis, can lead to a
sequence of events that result in loss of function for a ﬁnely
tuned enzyme catalyst.
5. Differences in Coenzyme
BindingandSpeciﬁcity
T h ea c t i v es i t ef u n c t i o n a lg r o u p so fA S A D Ha r ea l r e a d y
poised to accommodate amino acid substrate binding in
the apoenzyme. However, the binding of NADP is required
to induce a domain closure that sets up the active site for
catalysis. NADP binding and the coupled domain closure
are driven by numerous interactions between the enzyme
and the molecular features that are distributed throughout
the coenzyme. In vcASADH, Arg9 is repositioned during
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Lys246
Arg103
Asn135
Cys136
ASA
W1 W2
PO4
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=
Figure 4: The oxyanion binding site in H. inﬂuenzae ASADH. Each
of the oxyanion substrates and inhibitors interacts with the same
protein ligands, Arg103 and Lys246, and is bound within attacking
distance of the covalent acyl-enzyme intermediate. In the substrate
structures with either phosphate or arsenate a second oxyanion
molecule is bound to Ser100, Lys242, and Lys246 (ﬁgure adapted
from reference [28]).
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Figure 5: Diﬀerences in coenzyme binding in ASADHs. An overlay
of the NADP binding orientations in V. cholerae ASADH (blue),
S. pneumonia ASADH (red), and C. albicans ASADH (green). The
center of the adenine ring in the Gram-positive and fungal enzymes
has shifted by about 8.5 ˚ A with respect to its position in vcASADH,
and the position of the exocyclic amine on C6 has moved by nearly
14 ˚ A (ﬁgure adapted from reference [20]).
NADP binding to form an electrostatic interaction with the
2 -phosphate, with additional hydrogen-bonds to phosphate
from Thr36 and Ser37 (Figure 5). A consensus sequence,
SGxG, present in each branch of the ASADH family inter-
acts via backbone carbonyl hydrogen-bonds to the amide
nitrogen of the nicotinamide, while a conserved glutamine
(Gln350) in the bacterial enzymes and a corresponding
asparagine in the archaeal enzyme are in position to
hydrogen-bond to the amide oxygen (Figure 5).
BindinginteractionstotheadenineringofNADPareless
conserved between the Gram-negative and Gram-positive
bacterial enzymes, leading to some drastic diﬀerences inJournal of Amino Acids 7
coenzymebinding.TheadeninebaseinvcASADHisoriented
by a cation-π interaction with Arg9 (Figure 5) in the
consensusGxxGxxGsequencewhichispartoftheRossmann
nucleotide fold [29]. A surface loop spanning from Leu189
to Ser195 closes around NADP in these Gram-negative
enzymes, with the exocyclic N6 of the adenine base forming
a hydrogen-bond with the backbone carbonyl of a proline
(Pro192)locatedonthehelicalsubdomainfromtheopposite
subunit of the dimer (Figure 2). This interaction plays a crit-
ical role in the change from an open to a closed enzyme con-
formation upon coenzyme binding [16]. The overall domain
movements encountered in the transition from the apoen-
zyme to the NADP complex in Gram-positive spASADH are
similar to those observed for vcASADH [15]. Rotation of
the N-terminal domain toward the active site in response
to NADP binding appears to be a universal mechanism
utilizedthroughouttheASADHfamily.However,noneofthe
interactionsthatdrivedomainclosureinbothecASADHand
vcASADHareobservedinspASADH.Thus,facilitationofthe
commonly observed domain closure in spASADH must be
driven by a diﬀerent set of interactions than those that drive
the same closure in the Gram-negative ASADHs.
A completely new binding pocket for the adenine base
is found in spASADH, along with an altered 2 -phosphate
binding site, from that previously observed in the Gram-
negative enzymes. The adenine binding pocket in spASADH
is forged between an α-helix and the coenzyme binding
loop of the N-terminal domain. Interactions between the
adenine ring and the side chains of Thr76 and Ser37, along
with a cation-π interaction with Arg39, serve to anchor the
adenine ring in this pocket [18]. These new interactions
cause the adenine ring to adopt an altered position in
spASADH formed by rotation around the bonds linking
the nicotinamide and adenine ribose with the bridging
diphosphates. As a consequence the center of the adenine
ring is shifted by about 8.5 ˚ A with respect to its position
in NADP bound in vcASADH, and the position of the
exocyclic amine on C6 that formerly interacted with Pro192
from the adjacent subunit has been displaced by nearly 14 ˚ A
(Figure 5). However, the 2 -phosphate of NADP bound in
the spASADH structure moves less than 5 ˚ Ar e l a t i v et oi t s
position in vcASADH, and the phosphate binding groups
move to accommodate this shift.
Comparison of the coenzyme binding site between
archaeal mjASADH and the bacterial enzymes also shows
some conserved similarities. In bacterial ASADHs the back-
bone amino groups from a methionine and valine are
hydrogen-bond donors to the pyrophosphate of NADP
(Figure 5), and a change from methionine to serine in the
mjASADH structure does not alter these pyrophosphate
interactions. A similar reorientation of the adenine ring
to that observed in spASADH is seen in the binding of
NADP to the ASADH from M. jannaschii [19]. An extended
surface loop in mjASADH (from residues 40 to 77) forms the
binding pocket for this conformation of the bound NADP.
Speciﬁc contacts between the adenine ring and the enzyme
include two hydrophobic interactions to Leu91 and Leu95
that are within 4.0 ˚ A of the plane of the adenine ring and
a cation-π interaction with Arg39. Similar interactions and
a closely related coenzyme orientation are also found in the
binding of the adenine ring in the fungal enzyme structure
(caASADH) [20]( Figure 5).
These changes in coenzyme conformation and in the
nature of the interactions with the 2 -phosphate of NADP
in the mjASADH structure suggest the possibility of altered
coenzyme speciﬁcity relative to that seen for the well-studied
Gram-negative bacterial enzymes. Preference for NADP
versus NAD binding in enzymes is mediated through speciﬁc
interactions with either the 2 -phosphate of NADP or the
2 -hydroxyl of NAD. The ASADHs from E. coli, V. cholerae,
and H. inﬂuenzae are each highly speciﬁc for NADP. The
structure of the NADP complex in vcASADH shows that
the 2 -phosphate group is bound by the same arginine that
stacks against the adenine base, along with three hydrogen
bonds that are formed with two serines and a threonine.
This arginine in vcASADH is not conserved in mjASADH
but instead is replaced by a threonine that is still in the
correct position to form a potential hydrogen-bond with
the 2 -phosphate of NADP but, unlike in vcASADH, is not
capable of binding to the adenine base.
The possibility of expanded coenzyme speciﬁcity for
the archaeal enzyme was examined kinetically by testing
both NADP and NAD as substrates near the physiological
temperatures for this thermophilic organism. mjASADH is
found to have comparable catalytic rates with either NAD
or NADP when examined at 70
oC[ 19]. However, this
enzyme still shows a preference for NADP over NAD as its
coenzyme, with a Michaelis constant that is 130-fold lower
for NADP (KNADP = 13μM) compared to that for NAD
(KNAD = 1700μM). It appears that the relaxed speciﬁcity
for NADP in mjASADH is primarily due to absence of
this critical arginine residue, since the positively charged
guanidinium group of this arginine interacts directly with
the negatively charged 2 -phosphate of NADP. An additional
explanation for this altered coenzyme speciﬁcity comes from
the structure of the NADP complex in which the adenine
and ribose end of the NADP is bound in a completely
diﬀerent binding pocket in archaeal mjASADH compared to
the Gram-negative bacterial enzyme family.
6. The Presenceof an Intersubunit
Communication Channel
The subunit interface in the homodimer for both the
bacterial and archaeal ASADHs is composed primarily of
hydrophobicβ-sheets.TheGram-negativebacterialASADHs
have the largest dimer interface, formed by a conserved
hydrophobic β-sheet and complemented by the helical
subdomain to create over 3400 ˚ A
2 of buried surface area
(Figure 2). This subdomain is also present in the Gram-
positive bacterial spASADH, but a 16-residue deletion results
in a single α-helix followed by an unstructured loop forming
the top portion of the dimer interface with about 2600 ˚ A
2
of total buried surface area. A 48-amino acid deletion in
mjASADH results in the complete removal of the helical
subdomain that makes a signiﬁcant contribution to the8 Journal of Amino Acids
dimer interface in ecASADH. As a consequence the ther-
mophilic mjASADH structure has a much smaller dimer
interface of about 2000 ˚ A
2. The enzyme from C. albicans
(caASADH) is also missing the helical subdomain, with
the 44 amino acids that constitute this helix-turn-helix
motif in the Gram-negative enzyme forms replaced by an
unstructured 3 amino acid loop [20]. As a consequence this
fungal enzyme has the smallest dimer interface (∼1800 ˚ A
2)
and the lowest percentage of buried surface area among
the structurally characterized ASADHs. Interestingly, there
is good correlation between the dimer interface area and
enzymatic activity, with the enzyme forms possessing the
highest buried dimer surface having the highest catalytic
activity [30]. This correlation suggests that intersubunit
communication in the ASADH dimer is critical to promote
highly eﬃcient catalysis.
A network of hydrogen bonds has been identiﬁed
across the dimerization interface that is proposed to allow
active site to active site communication in the functional
ASADH dimer from the bacterial enzyme branch [16].
These structural observations support the earlier kinetic
experiments that had suggested an alternating site reactivity
model for ASADH catalysis [31] .T h ea c t i v es i t eG l u 2 4 0i n
s u b u n i tAo fvcASADH is positioned through a hydrogen-
bond to Gln161 (Figure 3). Gln161 also forms a hydrogen-
bond with the backbone amide of Thr159, which in turn is
hydrogen-bonded through its side chain hydroxyl group to
the hydroxyl group of Tyr160 across the dimer interface in
subunit B (Figure 6). A complementary series of interactions
links the active site Glu240 in subunit B to Tyr160 in subunit
A, such that each active site is linked to an amino acid in
the adjacent subunit through a network of three hydrogen-
bonds. The orientation of the Tyr160 residues at the
domain interface is crucial to maintaining this network. The
tyrosine side chain position is stabilized by π-stacking to the
tyrosine from the other subunit and also by a perpendicular
π-stacking interaction with Phe345 in the same subunit
(Figure 6).
The structure of mjASADH does not allow the inter-
subunit communication route that is seen in the bac-
terial enzymes. Two methionines are present within the
dimerization interface region of mjASADH that contribute
to the hydrophobic subunit interactions, but replace the
conserved tyrosines in each subunit that forms the heart of
the hydrogen-bonding network bridging between the two
active sites (Figure 6). The phenylalanines that stabilize these
tyrosines through π-stacking have also been replaced in
the archaeal ASADH branch with a conserved threonine
(Figure 6). These amino acids that are crucial for inter-
subunit communication have also been replaced in the
caASADH enzyme. The base-stacked tyrosine is substituted
by either leucine or methionine at this position in all
fungal ASADHs, while the stabilizing phenylalanine is now
a conserved valine in this branch of the enzyme family
[20]. These amino acid replacements disrupt the intersub-
unit hydrogen-bonding network observed in Gram-negative
ASADHs, leading to the loss of this communication channel.
The alternating sites reactivity observed in the bacterial
Thr328 (A)
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Cys134 (A)
Glu240 (A)
Met183 (B)
Thr328 (B)
Phe345 (B)
Phe345 (A)
Gln161 (A)
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Tyr160 (A)
Cys134 (B)
Glu240 (B) Active site (A) 
Active site (B) 
Thr159 (B)
Thr159 (A)
Gln161 (B)
Figure 6: Proposed intersubunit communication channel in bacte-
rial ASADHs. The subunit interface of vcASADH (gray) is bridged
byahydrogen-bondingnetwork(dottedlines)connectingtheactive
sites of each subunit and stabilized by π-stacking interactions
(dashed lines). In the subunit interface of mjASADH (green)
replacement of Tyr160 with Met183 interrupts the hydrogen-
bonding network, and replacement of Phe345 with Thr328 disrupts
the π-stacking stabilization.
forms of ASADH is likely absent in both the archaeal and
fungal enzymes and could explain the very low catalytic
activity in these enzyme forms despite the presence of
an identical constellation of active site functional groups
throughout the ASADH enzyme family.
7.CatalyticMechanismand
Covalent Intermediates
The proposed catalytic mechanism of ASADH in the reverse
(nonphysiological) direction involves the initial attack of the
active site cysteine nucleophile (Cys136) on the carbonyl
carbon of the substrate ASA. The enzyme-bound tetrahedral
intermediate produced by this reaction (Figure 7,s t r u c t u r e
a) is set up to transfer a hydride ion to the NADP
coenzyme bound at an adjacent site, leading to an acyl-
enzymeintermediate(Figure 7,structureb).A ttackofbound
phosphate at the carbonyl carbon of this intermediate
produces a second enzyme-bound tetrahedral intermediate
(Figure 7, structure c). Collapse of this intermediate with
expulsion of the enzyme thiolate group yields the β-aspartyl
phosphate product and leaves the enzyme ready to bind
another molecule of ASA and repeat the catalytic cycle.
The chance to characterize a true intermediate in an
enzyme-catalyzed reaction is a rare opportunity to bridge a
mechanistic gap that is generally only hypothesized between
the substrate and the product complexes, or extrapolated
fromintermediate-analoguestructures.FortheASADHsthis
feat has been accomplished twice, capturing and structurally
characterizing two diﬀerent reactive intermediates in the
catalytic cycle of this enzyme and lending structural support
to this proposed mechanism.
A ternary complex produced by diﬀusing the substrates
ASA and phosphate into crystals of hiASADH was examined
with the aim of determining the role of diﬀerent activeJournal of Amino Acids 9
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Figure 7:Catalyticmechanismofthereversibleaspartateβ-semialdehydedehydrogenase-catalyzedconversionofASAtoaspartylphosphate.
(a)TetrahedralintermediatederivedfromnucleophilicattackonASA.(b)Acyl-enzymeintermediateproducedbyhydridetransfertoNADP.
(c) Proposed tetrahedral intermediate obtained from phosphate attack on the acyl-enzyme.
site groups in the catalytic mechanism. However, what was
observed was not the structure of the enzyme-substrate
complex, but instead the structure of the actual tetrahedral
intermediate in the catalytic cycle of ASADH (structure a
in Figure 7). The bound aspartyl intermediate was modeled
into the continuous density emanating from the side chain
of the cysteine nucleophile [17], and this structure clearly
shows the tetrahedral geometry around the carbon that is
covalently attached to the active site cysteine thiolate group
(Figure 8). Subsequent hydride transfer from this tetrahedral10 Journal of Amino Acids
His252
(His277)
Cys128
(Cys136)
Glu220
(Gly243)
Asn127
(Asn135)
Arg99
(Arg103)
ASAtetr
ASAacyl
Arg245
(Arg270)
Figure 8: Overlay of the tetrahedral intermediate (ASAtetr,g r a y
bonds and black labels) produced in hiASADH and the acyl-
enzyme intermediate (ASAacyl, magenta bonds and labels) obtained
in spASADH. The change in geometry of the acyl carbon of this
bound intermediate is tracked by shifts in the substrate binding
groups, Asn127, Glu220, and Arg245. H. inﬂuenzae numbering is
in parentheses.
intermediate to NADP would lead to formation of the acyl-
enzyme intermediate. However, exclusion of the coenzyme
from the crystallization conditions eliminates the hydride
transfer step that is required for the reaction to proceed, thus
stopping the catalytic cycle at this stage and allowing the
determination of this important structure.
The structure of the acyl-enzyme intermediate (structure
bi nFigure 7) was also determined by running the reaction
in the nonphysiological direction. Soaking the spASADH-
NADP complex crystals with the substrate ASA allows the
catalytic cycle to proceed up to formation of the acyl-
enzymeintermediate[18].Exclusionofphosphateeliminates
the nucleophile required to complete the catalytic cycle.
Kinetic studies had previously shown that the acyl-enzyme
can be quite stable in the absence of phosphate [32]. The
reﬁned structures show the key diﬀerences between the
tetrahedral intermediate and the acyl-enzyme intermediate.
The position of the substrate binding groups that interact
with these intermediates shift only slightly between these
two structures, with the largest movements caused by the
conversion from a tetrahedral carbon geometry in the
previous intermediate structure to a planar carbon geometry
in the acyl-enzyme (Figure 8).
8. Concluding Remarks
Throughacombinationofkinetic,mutagenic,andstructural
studies the detailed catalytic mechanism of the aspartate
β-semialdehyde dehydrogenases has been deﬁned, and the
essential functional groups that play a role in substrate
binding, catalysis, and regulation have each been identiﬁed.
Subtle changes in any of these critical functional groups
are suﬃcient to alter the ﬁnely tuned catalytic machinery
of this enzyme, leading to enzyme forms with signiﬁcantly
impaired activity. Diﬀerences have been observed between
the members of this enzyme family, isolated from bacte-
rial, archaeal, and fungal species, regarding their catalytic
eﬃciency, their coenzyme selectivity, and their mode of
catalysis. This extensive body of work on the diﬀerent
members of the ASADH family now allows us to evaluate
this enzyme as a drug target. Compounds are now being
screened [33] that can potentially recognize these structural
and functional diﬀerences to produce initial inhibitors that
can be developed into species-speciﬁc antimicrobials against
this key enzyme in an essential metabolic pathway.
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